07 Jan 2019 Cingulate Therapeutics to Present at Biotech Showcase™ 2019 in San Francisco
Kansas City, KS – (January 7, 2019) – Cingulate Therapeutics LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its proprietary drug delivery technology, today announced that Shane J. Schaffer, PharmD, Chairman and CEO of Cingulate